| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5512168 | International Journal of Biological Macromolecules | 2017 | 37 Pages |
Abstract
Electrophoresis analysis of the purified protein revealed a single band with a molecular mass of about 3 kDa. Treatment with TICMS at six doses resulted in a significant decrease of endothelial cell proliferation with an IC50 value of about 20 μg/ml. Tubulogenesis assay revealed that a dose dependent anti-angiogenic activity of TICMS (5-40 μg/ml). Also, TICMS had inhibitory effects on VEGF, MMP-2 and MMP-9 secretion. Our docking result speculated that TICMS could bind to the cleft between the αVβ3 integrin and it able to decrease the activity of this receptor. The TICMS was also able to interact with VEGFR1 receptor, but with low probability. Based on our study, TICMS could be used as a specific angiogenesis inhibitor.
Keywords
PDBPBS containing Tween 20BBIVEGFRFCSHUVECERKPBSTFBSMMPPBSDMEMBSAMTTbovine serum albuminSDS-PAGESodium dodecyl sulfate polyacrylamide gel electrophoresisEnzyme-linked immunosorbent assayELISAfetal bovine serumfetal calf serumEndothelial cellHuman umbilical vein endothelial cellsVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)Phosphate buffered salinelactate dehydrogenaseLDHTumor metastasisMatrix metalloproteinasesDulbecco’s modified eagle’s mediumMigrationBowman-Birk inhibitorProtein Data BankTraditional medicineExtracellular signal–regulated kinaseVEGF receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Hassan Rasouli, Sharham Parvaneh, Azadeh Mahnam, Mohsen Rastegari-Pouyani, Zohreh Hoseinkhani, Kamran Mansouri,